SGX share price ticks up as investors eye record derivatives, China ETF push and Feb 5 results
22 January 2026
1 min read

SGX share price ticks up as investors eye record derivatives, China ETF push and Feb 5 results

Singapore, Jan 22, 2026, 15:19 SGT — Regular session

  • Shares in Singapore Exchange ticked up 0.35% in afternoon trading, hovering close to recent peaks following a solid start to 2025
  • Watch if increased trading volume continues through the next earnings report
  • SGX has bolstered its push to expand cash-equities and ETF trading with a fresh China-focused ETF listing

Shares of Singapore Exchange Ltd ticked up Thursday as traders highlighted renewed chatter about the bourse operator’s trading momentum and a steady flow of new product launches.

Shares of the company, listed as S68, climbed 0.35% to S$17.37 by 3:18 p.m. local time, moving between S$17.34 and S$17.54 on the day. Trading volume hit roughly 1.18 million shares. (Source: 1 )

Why it matters now: SGX’s earnings hinge on trading and clearing volumes. When investors hedge or adjust positions, usually through derivatives—contracts linked to an underlying asset—the exchange typically experiences a boost in activity and fee revenue.

Investors are now eyeing the upcoming financial results to gauge how much of last year’s turnover boost is holding up, and to see the implications for guidance and dividends.

SGX reported earlier this month that its 2025 derivatives volume jumped 10%, hitting a record 329 million contracts. December’s securities turnover value surged 29% year-on-year to S$25.8 billion. The exchange also highlighted a full-year daily average securities value nearing S$1.5 billion — the strongest since 2010. (Source: 2 )

On Thursday, The Straits Times reported that SGX will continue grouping cash equities and equity derivatives under the same equities category, even as cash equities show stronger prospects. Chief financial officer Daniel Koh described the market as possibly being in “the early stages of a virtuous cycle.” Meanwhile, Shekhar Jaiswal, head of equity research at RHB Bank Singapore, expects fixed income, currencies and commodities (FICC) derivatives to “keep compounding faster” as product offerings grow. (Source: 3 )

SGX is expanding its exchange-traded fund offerings on the cash-equities front. On Tuesday, CSOP Asset Management launched Singapore’s first CSI A500 Index ETF on SGX, pricing shares at S$1 each with an annual management fee of 0.89%. (Source: 4 )

According to SGX’s IPO performance page, the ETF pulled in about S$46.756 million at its offer price. By Jan. 21, it closed at S$0.992, slipping 0.8% below that initial price. (Source: 5 )

Yet the recent rally has pushed expectations higher. A slowdown in volatility, fading China-related hedging activity, or a dip in cash-equities trading could all weigh on fee growth and make the stock vulnerable to profit-taking.

The next key date is Feb. 5, when SGX will release its first-half FY2026 results ahead of the market open, with a briefing to follow led by CEO Loh Boon Chye and Koh. (Source: 6 )

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Wilmar stock rises in Singapore as palm oil firms — what investors are watching next
Previous Story

Wilmar stock rises in Singapore as palm oil firms — what investors are watching next

Yangzijiang Shipbuilding shares slip again in Singapore trade as tariff headlines linger
Next Story

Yangzijiang Shipbuilding shares slip again in Singapore trade as tariff headlines linger

Go toTop